Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Eating and Weight Disorders : EWD|July 19, 2022
Bariatric surgery for metabolic unhealthy obesity (MUO) during the COVID era: short-term results of a high-volume centerValeria Guglielmi, Michela Campanelli, Emanuela Bianciardi, et al.
Obesity Research & Clinical Practice|January 12, 2022
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-upAlessandro Anselmo, Leandro Siragusa, Bruno Sensi, et al.
Nutrients|March 4, 2020
The Symptom-Checklist-K-9 (SCL-K-9) Discriminates between Overweight/Obese Patients with and without Significant Binge Eating Pathology: Psychometric Properties of an Italian VersionClaudio Imperatori, Emanuela Bianciardi, Cinzia Niolu, et al.
Obesity Surgery|June 3, 2015
Gender Influence on Long-Term Weight Loss and Comorbidities After Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass: a Prospective Study With a 5-Year Follow-upFederico Perrone, Emanuela Bianciardi, Domenico Benavoli, et al.
Frontiers in Surgery|July 22, 2025
Preoperative remote consultation for a green bariatric surgery: can telemedicine be safe for patients and sustainable for the environment?Luigi Eduardo Conte, Michela Orsi, Alessandro Peruzzi, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 26, 2012
Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndromeFrancesca Schinzari, Manfredi Tesauro, Valentina Rovella, et al.
Obesity Surgery|April 27, 2002
Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patientsMichel Gagner, Paolo Gentileschi, John de Csepel, et al.
Frontiers in Public Health|December 14, 2020
Bariatric Surgery Closure During COVID-19 Lockdown in Italy: The Perspective of Waiting List CandidatesEmanuela Bianciardi, Claudio Imperatori, Cinzia Niolu, et al.
Obesity Surgery|April 9, 2021
Transhiatal Migration After Laparoscopic Sleeve Gastrectomy: Myth or Reality? A Multicenter, Retrospective Study on the Incidence and Clinical ImpactPietro Termine, Cristian Eugeniu Boru, Angelo Iossa, et al.
Vascular Pharmacology|August 7, 2022
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptorsAlessandro De Stefano, Francesca Schinzari, Nicola Di Daniele, et al.
Pageof 9